UnitedHealthcare’s Golden Rule Introduces Cost-Effective Dental and Vision Coverage Options for Consumers in Six States

Tue, 29 Sep 2009 14:00:00 0500

INDIANAPOLIS-(Business Wire)-September 29, 2009 - UnitedHealthcare’s Golden Rule Insurance Company has introduced new cost-effective dental and vision care coverage options for individuals and families in Alaska, Arizona, Colorado, Iowa, South Dakota and Wyoming.

The new dental...

Computable Genomix Announces Contest For Genomics Researchers

Tue, 29 Sep 2009 12:00:00 0500

MEMPHIS, Tenn.-(Business Wire)-September 29, 2009 - Memphis-based Computable Genomix today announced it will launch a contest on Oct. 1, 2009, to coincide with the release of GeneIndexer, the company’s next-generation Web-based text-mining tool.

Publish or Perish will...

pSivida Reports Safety and Efficacy Results from 18-Month Interim Readout of Human PK Iluvien® Study

Tue, 29 Sep 2009 12:00:00 0500

WATERTOWN, Mass.-(Business Wire)-September 29, 2009 - pSivida Corp (NASDAQ: PSDV)(ASX: PVA), a leading drug delivery company that has developed two of the only three products approved by the FDA for the long-term, sustained release delivery of drug to treat chronic back of the eye disease...

Research and Markets: The Ophthalmic Pharmaceutical Market Outlook to 2014: Competitive Landscape, Pipeline Analysis, Growth Opportunities and Market Forecasts - Now Available

Fri, 25 Sep 2009 08:43:00 0500

DUBLIN-(Business Wire)-September 25, 2009 - Research and Markets (

PerkinElmer Launches Columbus™ 2.0 High Content Screening Platform for High-Volume Image Data Management and Analysis

Mon, 21 Sep 2009 12:00:00 0500

BOSTON-(Business Wire)-September 21, 2009 - At the High Content Analysis East conference...

Reportlinker Adds The Ophthalmic Pharmaceutical Market Outlook To 2014: Competitive Landscape, Pipeline Analysis, Growth Opportunities and Market Forecasts

Mon, 21 Sep 2009 07:15:00 0500

NEW YORK-(Business Wire)-September 21, 2009 - Reportlinker.com announces that a new market research report is available in its catalogue.

EBD Group and Defined Health Form an Alliance on Conference Content

Wed, 16 Sep 2009 23:40:00 0500

CARLSBAD, Calif. & ZURICH, Switzerland & FLORHAM PARK, N.J.-(Business Wire)-September 16, 2009 - EBD Group and Defined Health today announced the formation of an alliance that will help biopharmaceutical firms gain the insights they need to create and execute successful strategy. Under...

Blind Patient Regains Sight with “Eyetooth” Implanted in Her Eye

Wed, 16 Sep 2009 20:09:00 0500

MIAMI-(Business Wire)-September 16, 2009 - Blind for nine years, Sharron “Kay” Thornton has just regained her sight through a first-in-the-U.S. surgical procedure at Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine. The procedure — modified...

Los Angeles Cosmetic Surgeon Discusses Non-Surgical Facial Rejuvenation in Harper’s Bazaar Magazine

Wed, 16 Sep 2009 04:00:00 0500

LOS ANGELES-(Business Wire)-September 16, 2009 - Dr. Kenneth D. Steinsapir, M.D., a Los Angeles...

Pilkington Acquires License from Research Frontiers to Produce and Offer Environmentally Friendly SPD-Smart Automotive Glass Products

Tue, 15 Sep 2009 12:30:00 0500

FRANKFURT-(Business Wire)-September 15, 2009 - Today at the Frankfurt International Motor Show, Pilkington Group Limited announced that it has acquired a new license from Research Frontiers Inc. (Nasdaq: REFR) to offer SPD-Smart automotive end-products globally. Research Frontiers is the...

OptiMedica Names Alan Marquardt as New Vice President, Regulatory, Clinical and Quality

Tue, 15 Sep 2009 11:00:00 0500

SANTA CLARA, Calif.-(Business Wire)-September 15, 2009 - Global ophthalmic company OptiMedica Corp. has appointed Alan Marquardt to the newly created position of vice president, regulatory, clinical and quality. Marquardt joins OptiMedica with more than two decades of equivalent senior management...

AzaSite® Production Increased in Response to Erythromycin Ophthalmic Ointment Shortage

Mon, 14 Sep 2009 20:03:00 0500

ALAMEDA, Calif.-(Business Wire)-September 14, 2009 - InSite Vision Incorporated (OTCBB: INSV) today announced that Inspire Pharmaceuticals, its commercial partner for AzaSite® (azithromycin ophthalmic solution) 1% in the U.S and Canada, has committed to increasing production of AzaSite in...

Alcon to Acquire Swiss Biotechnology Firm, ESBATech AG

Sun, 13 Sep 2009 22:01:00 0500

HUENENBERG, Switzerland & ZURICH-(Business Wire)-September 13, 2009 - Alcon (NYSE:

Fitch Ratings Affirms McKesson's IDR at 'BBB+'; Outlook Stable

Thu, 10 Sep 2009 14:55:00 0500

CHICAGO-(Business Wire)-September 10, 2009 - Fitch Ratings has affirmed the Issuer Default Rating (IDR) and debt ratings for McKesson Corp. (MCK) as follows.

—IDR at 'BBB+';

—Senior unsecured credit facility at 'BBB+';

—Senior...

Reportlinker Adds China Medical Equipment Market Analysis and Forecasts to 2015

Thu, 10 Sep 2009 13:22:00 0500

NEW YORK-(Business Wire)-September 10, 2009 - Reportlinker.com announces that a new market research report is available in its catalogue.

Acucela Appoints Glen Y. Sato to Board of Directors

Wed, 09 Sep 2009 12:00:00 0500

BOTHELL, Wash.-(Business Wire)-September 9, 2009 - Acucela, a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today the appointment of Glen Y. Sato, a partner in the Life Sciences and Corporate practice groups of the law firm Cooley...

pSivida to Webcast Presentation at Rodman & Renshaw Health Care Conference

Wed, 09 Sep 2009 11:30:00 0500

BOSTON-(Business Wire)-September 9, 2009 - pSivida Corp, (NASDAQ:PSDV)(ASX:PSD)(FF:PSI), a leading drug delivery company, today announced it will webcast a live presentation at the Rodman & Renshaw Annual Health Care Conference in New York, September 10. Dr. Paul Ashton, president and chief...

Amerinet Named Provider of Choice by National Rural Health Association Partnership

Tue, 08 Sep 2009 15:00:00 0500

ST. LOUIS-(Business Wire)-September 8, 2009 - In recognition of their commitment to helping rural healthcare providers reduce costs and improve quality, Amerinet, a leading national healthcare group purchasing organization, has been named a “Provider of Choice” by the National...

Lux Biosciences to Present at the Thomas Weisel Partners Health Care Conference

Tue, 08 Sep 2009 12:01:00 0500

JERSEY CITY, N.J.-(Business Wire)-September 8, 2009 - Lux Biosciences, a privately held biotechnology company focused on the treatment of ophthalmic diseases, announced today that Ulrich Grau, Ph.D., the company’s president and chief executive officer, will present at the Thomas Weisel...

Hi-Tech Pharmacal to Release First Quarter Earnings and Hold Conference Call on September 9, 2009

Fri, 04 Sep 2009 12:00:00 0500

AMITYVILLE, N.Y.-(Business Wire)-September 4, 2009 - Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) announced that the Company will release results for its first quarter of Fiscal Year 2010 ended July 31, 2009, prior to the market opening on Wednesday September 9, 2009 and will hold a conference call...

Christopher Payan to Depart Emerging Vision

Thu, 03 Sep 2009 15:00:00 0500

GARDEN CITY, N.Y.-(Business Wire)-September 3, 2009 - Emerging Vision, Inc. (OTCBB – ISEE) today announced that Christopher Payan, the Company’s Chief Executive Officer and President, and the Company have determined not to renew Mr. Payan’s employment agreement which is set to expire...

Vivakor Announces Award of Grant from the National Institutes of Health-National Eye Institute

Thu, 03 Sep 2009 14:04:00 0500

IRVINE, Calif.-(Business Wire)-September 3, 2009 - Vivakor, Inc. (OTCBB: VIVK) announced that the National Institutes of Health-National Eye Institute has awarded a grant to Vivakor, Inc. in Coralville, IA through the Small Business Innovation Research Awards.

Vivakor will use...

Merck Launches SAFLUTAN® (tafluprost) in International Markets

Thu, 03 Sep 2009 08:00:00 0500

WHITEHOUSE STATION, N.J.-(Business Wire)-September 3, 2009 - Merck & Co., Inc. has launched SAFLUTAN^® (tafluprost) in the United Kingdom and Spain, and additional launches in other countries are expected over the next several months, pending regulatory approvals, the...

Dioptics Launches Haven Fits Over Sunwear™

Wed, 02 Sep 2009 21:58:00 0500

SMITHFIELD, R.I.-(Business Wire)-September 2, 2009 - Dioptics Medical Products, Inc., a subsidiary of FGX International Inc., is launching Haven Fits Over Sunwear™ at the 2009 Vision Expo West show in Las Vegas, NV. This special collection features premium polarized sunglasses and ClipOns...

Acucela to Present at the Rodman & Renshaw 11th Annual Healthcare Conference

Wed, 02 Sep 2009 12:00:00 0500

BOTHELL, Wash.-(Business Wire)-September 2, 2009 - Acucela, a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that Ryo Kubota, M.D., Ph.D., Acucela’s chairman, president and chief executive officer, will present a company...

MedAssets to Present at Two Investor Conferences in September

Thu, 27 Aug 2009 14:36:00 0500

ATLANTA-(Business Wire)-August 27, 2009 - MedAssets, Inc. (NASDAQ: MDAS) today announced that its management team will participate in investment firm conferences in September 2009. The Company is scheduled to present at Baird's 2009 Health Care Conference on Thursday, September 10 at 9:00 am ET...

Visiogen Announces Formation of European Subsidiary, Commencement of Controlled Commercial Release of Synchrony® Accommodating IOL

Tue, 17 Feb 2009 16:59:00 0500

ROME-(Business Wire)-February 17, 2009 - Visiogen announced the formation of its European subsidiary and the commencement of the controlled commercial release of the Synchrony® accommodating intraocular lens in Europe at the winter meeting of the European Society of Cataract and Refractive...

Research and Markets: A Global Strategic Analysis on the Intraocular Lenses Markets in Millions of US$

Tue, 17 Feb 2009 15:00:00 0500

DUBLIN, Ireland-(Business Wire)-February 17, 2009 - Research and Markets (

Alcon Fourth Quarter Diluted EPS Increased 12.8 Percent

Thu, 12 Feb 2009 02:18:00 0500

HÜNENBERG, Switzerland-(Business Wire)-February 12, 2009 - Alcon, Inc. (NYSE:ACL):

2008 Highlights

Sales rose 12.4 percent to $6.29 billion

Raquel Welch Stars in Foster Grant TV Commercial

Mon, 09 Feb 2009 17:59:00 0500

SMITHFIELD, R.I.-(Business Wire)-February 9, 2009 - FGX International (NASDAQ: FGXI), a leading eyewear designer and marketer, announced today that it has released the latest television ad campaign for Foster Grant, featuring Hollywood legend Raquel Welch. The ads will begin airing on national...

Biotechs Seek Partners at BIO-Europe Spring® as Alternative to Financial Markets

Fri, 06 Feb 2009 15:25:00 0500

CARLSBAD, Calif. & ZURICH & MILAN-(Business Wire)-February 6, 2009 - The intensity of partnering activities among biotech executives continues to increase in the wake of the collapse of traditional sources for financing, according to EBD Group, producer of the annual BIO-Europe...

Advanced Medical Optics, Inc. Gives Notice of Anticipated Fundamental Change and Merger to Holders of Convertible Senior Subordinated Notes

Fri, 06 Feb 2009 14:00:00 0500

SANTA ANA, Calif.-(Business Wire)-February 6, 2009 - Advanced Medical Optics, Inc. (AMO) (NYSE: EYE) announced that, pursuant to the terms of the indentures (the “Indentures”) governing its (i) 2.50% convertible senior subordinated notes due 2024, (ii) 1.375% convertible senior subordinated...

Allergan Reports Fourth Quarter 2008 Operating Results and Announces Restructuring

Wed, 04 Feb 2009 14:00:00 0500

IRVINE, Calif.-(Business Wire)-February 4, 2009 - Allergan, Inc. (NYSE: AGN) today announced operating results for the quarter ended December 31, 2008. Allergan also announced that its Board of Directors has declared a fourth quarter dividend of $0.05 per share, payable on March 13, 2009 to...

ACADIA Pharmaceuticals to Present at the BIO CEO & Investor Conference on February 10, 2009

Tue, 03 Feb 2009 14:00:00 0500

SAN DIEGO-(Business Wire)-February 3, 2009 - ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it will present at...

Cataract Surgery and Macular Degeneration; Beauty in the Eye of the Beholder; Are Genes or Environmental Factors to Blame for Poorer Vision as We Age?

Mon, 02 Feb 2009 16:30:00 0500

SAN FRANCISCO-(Business Wire)-February 2, 2009 - Does cataract surgery increase the risk of vision loss in people with age-related macular degeneration (AMD)? How do people read faces to judge age or fatigue? Which has a larger impact on the “normal” decline of visual function as we age...

pSivida Corp. Names Paul Ashton, Ph.D. President and Chief Executive Officer

Mon, 02 Feb 2009 13:30:00 0500

WATERTOWN, Mass.-(Business Wire)-February 2, 2009 - pSivida Corp. (NASDAQ:PSDV)(ASX:PVA)(FF:PSI), a leading drug delivery company today announced that Paul Ashton, Ph.D. has been named President and Chief Executive Officer.

Dr. David J. Mazzo, Non-executive Chairman, pSivida Corp...

ZOLL Announces Filing of Patent Infringement Suit Against Alsius Corporation and Alsius Medical Corporation

Fri, 30 Jan 2009 17:15:00 0500

CHELMSFORD, Mass.-(Business Wire)-January 30, 2009 - ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, announced today that it had filed a lawsuit against Alsius Corporation (Nasdaq: ALUS) and Alsius Medical Corporation in the...

Akorn Announces Management Change

Fri, 30 Jan 2009 02:00:00 0500

LAKE FOREST, Ill.-(Business Wire)-January 30, 2009 - Akorn, Inc. (NASDAQ: AKRX) today announced that its President and Chief Executive Officer, Arthur Przybyl, is leaving the company and that, pending selection of a new President and Chief Executive Officer, a committee of three board members...

International Stem Cell Corporation Begins Pre-Clinical Trials on Human Corneal Epithelial Cells

Thu, 29 Jan 2009 13:15:00 0500

OCEANSIDE, Calif.-(Business Wire)-January 29, 2009 - International Stem Cell Corporation (OTCBB:

OPKO Receives FDA 510(k) Clearance for Spectral OCT SLO Combination Imaging System

Fri, 23 Jan 2009 14:13:00 0500

MIAMI-(Business Wire)-January 23, 2009 - OPKO Health, Inc. (NYSE Alternext US:OPK) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) to begin marketing in the United States its Spectral OCT SLO Combination Imaging System. Currently...

Orange 21 Inc. Announces $7.6 Million Rights Offering

Thu, 22 Jan 2009 23:24:00 0500

CARLSBAD, Calif.-(Business Wire)-January 22, 2009 - Orange 21 Inc. (NASDAQ:ORNG) today announced that it has launched a $7.6 million rights offering pursuant to which holders of its common stock, options and warrants, will be entitled to purchase additional shares of its common stock at a price...

OPKO Health Initiates Clinical Trial of the Aquashunt™ to Treat Glaucoma

Thu, 22 Jan 2009 18:49:00 0500

MIAMI-(Business Wire)-January 22, 2009 - OPKO Health, Inc. (AMEX:OPK) announced today that it has begun treating patients in a clinical trial of its Aquashunt™, a device for the treatment of refractory open angle glaucoma. The study, at two academic departments of ophthalmology, is designed...

Larry C. Renfro Named Executive Vice President UnitedHealth Group and Ovations Chief Executive Officer

Thu, 22 Jan 2009 14:45:00 0500

MINNEAPOLIS-(Business Wire)-January 22, 2009 - UnitedHealth Group (NYSE: UNH) today named Larry C. Renfro executive vice president UnitedHealth Group and chief executive officer of Ovations. Ovations is UnitedHealth Group’s seniors health business and the nation’s largest and most diversified...

Simon Stevens Appointed Executive Vice President UnitedHealth Group to Lead Enterprise-Wide Health Care Reform Engagement; Will Also Direct International Businesses and Global Expansion

Thu, 22 Jan 2009 14:45:00 0500

MINNEAPOLIS-(Business Wire)-January 22, 2009 - UnitedHealth Group (NYSE: UNH) announced today that Simon Stevens will serve as executive vice president, UnitedHealth Group, with major responsibilities in the areas of health care reform and global health interests.

In his new...

Genentech Announces Vice President Appointment in Research

Wed, 21 Jan 2009 18:07:00 0500

SOUTH SAN FRANCISCO, Calif.-(Business Wire)-January 21, 2009 - Genentech, Inc. (NYSE:DNA) today announced the appointment of Jennifer A. Doudna, Ph.D., to Vice President, Discovery Research. In this newly created position, Doudna will oversee the departments of protein chemistry and structural...

Examine the Global Ophthalmic Market: Focus on Glaucoma

Wed, 21 Jan 2009 10:06:00 0500

NEW YORK-(Business Wire)-January 21, 2009 - Reportlinker.com announces that a new market research report related to the Ophthalmic devices industry is available in its catalogue.

U.S. product sales of $9,503 million...

Online Resource Illustrates Basic Diagnosis Procedures for Medical School Students

Thu, 15 Jan 2009 16:40:00 0500

SKANEATELES FALLS, N.Y.-(Business Wire)-January 15, 2009 - Welch Allyn, a leading manufacturer of frontline medical products and solutions, today introduced Diagnosis 101, an online educational resource for

MacuCLEAR and Mystic Pharmaceuticals Agree To Collaborate on Macular Degeneration Phase I/II Clinical Trial

Tue, 13 Jan 2009 11:00:00 0500

PLANO, Texas-(Business Wire)-January 13, 2009 - MacuCLEAR, Inc. (“MacuCLEAR”) announced today it has entered into a collaborative business relationship with Mystic Pharmaceuticals Inc. for its upcoming Phase I/II Human Clinical Trials. MacuCLEAR is developing MC 1101, for the treatment and...

CYTTA Introduces Its New Wholly Owned Subsidiary

Mon, 12 Jan 2009 21:04:00 0500

FOUNTAIN HILLS, Ariz.-(Business Wire)-January 12, 2009 - CYTTA Corporation’s (OTCBB: CYTC) newly acquired wholly owned subsidiary Ophthalmic International (OI) is an innovative manufacturer of medical products. OI has developed and patented a 2-minute, non-invasive, cost effective, alternative...

Kevin Buehler Appointed President and CEO of Alcon; Cary Rayment to Continue as Chairman of the Board

Thu, 08 Jan 2009 23:50:00 0500

HÜNENBERG, Switzerland-(Business Wire)-January 8, 2009 - Alcon, Inc. (NYSE:ACL) announced today that on April 1, 2009 Kevin Buehler will become president and chief executive officer of Alcon, Inc. Cary Rayment will retire as president and chief executive officer effective March 31, 2009, but...

Alcon Announces Fourth Quarter 2008 Financial Release and Conference Call Dates

Thu, 08 Jan 2009 22:23:00 0500

HÜNENBERG, Switzerland-(Business Wire)-January 8, 2009 - Alcon, Inc. (NYSE: ACL) will report on its fourth quarter financial results for the period ended December 31, 2008 after the market close on Wednesday, February 11, 2009.

Management of the company will host a conference...

High Growth Reported for the World Optical Coatings Market

Thu, 08 Jan 2009 14:05:00 0500

NEW YORK-(Business Wire)-January 8, 2009 - Reportlinker.com announces that a new market research report related to the Paints - coatings - solvants industry is available in its catalogue.

Research and Markets: 'Global Ophthalmic Market: Focus On Glaucoma' Focuses on Glaucoma as a Major Ophthalmic Market

Tue, 06 Jan 2009 18:30:00 0500

DUBLIN, Ireland-(Business Wire)-January 6, 2009 - Research and Markets (

Medtech Insight and Windhover Conferences Announce their Upcoming "Investment In Innovation (In3) West” Conference March 2-4, 2009, Las Vegas, NV

Mon, 05 Jan 2009 14:00:00 0500

IRVINE, Calif.-(Business Wire)-January 5, 2009 - Medtech Insight, a division of Windhover Conferences and a leading provider of business information for the medical device industry, has announced that more than 30 early- to late-stage companies are confirmed to date to present at their upcoming...

Akorn-Strides, LLC Announces FDA Approvals for Sterile Vancomycin HCl USP, 500 mg/Vial; 1 g/Vial and Sterile Vancomycin HCl USP, 5 g/Vial Pharmacy Bulk Package

Wed, 31 Dec 2008 12:00:00 0500

LAKE FOREST, Ill.-(Business Wire)-December 31, 2008 - Akorn-Strides, LLC today announced that the U.S. Food and Drug Administration has granted approvals for two Abbreviated New Drug Applications (ANDAs) for Sterile Vancomycin HCl USP, 500 mg/vial, 1 g/vial and Sterile Vancomycin HCl USP, 5...

Eye Care and Eyewear Trends for 2009 and Beyond from the Editors of AllAboutVision.com

Tue, 30 Dec 2008 16:22:00 0500

SAN DIEGO-(Business Wire)-December 30, 2008 - What advances in eye care and eyewear can we expect in 2009 and beyond? The editors of AllAboutVision.com see the following trends and products emerging soon:

Researchers are working on liquid-based lenses...

FDA Approves Alcon’s AcrySof® IQ ReSTOR® +3.0 D Intraocular Lens

Tue, 23 Dec 2008 22:47:00 0500

HUENENBERG, Switzerland-(Business Wire)-December 23, 2008 - Alcon, Inc. (NYSE: ACL), the world’s leader in eye care and...

Californian Files Consumer Fraud Class Action against Advanced Medical Optics for Falsely Advertising Contact Lens Solution

Mon, 22 Dec 2008 19:20:00 0500

SANTA ANA, Calif.-(Business Wire)-December 22, 2008 - Lieff Cabraser Heimann & Bernstein, LLP, and Moscone, Emblidge & Quadra announced that Southern California-based Advanced Medical Optics, Inc. (“AMO”) was named as the defendant in a consumer fraud and false advertising class...

Californian Files Contact Lens Solution False Advertising Class Action Against Advanced Medical Optics, Announces the Schmidt Firm, LLP

Mon, 22 Dec 2008 17:43:00 0500

SANTA ANA, Calif.-(Business Wire)-December 22, 2008 - The Schmidt Firm, LLP in Dallas, Texas announced today that Southern California-based Advanced Medical Optics, Inc. (“AMO”) was named as the defendant in a consumer fraud and false advertising class action lawsuit. The case, Maria...

Examine the World Intraocular Lenses Market

Fri, 19 Dec 2008 10:25:00 0500

NEW YORK-(Business Wire)-December 19, 2008 - Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue.

Digital50.com Optical News RSS Feed

UnitedHealthcare’s Golden Rule Introduces Cost-Effective Dental and Vision Coverage Options for Consumers in Six States

Computable Genomix Announces Contest For Genomics Researchers

pSivida Reports Safety and Efficacy Results from 18-Month Interim Readout of Human PK Iluvien® Study

Research and Markets: The Ophthalmic Pharmaceutical Market Outlook to 2014: Competitive Landscape, Pipeline Analysis, Growth Opportunities and Market Forecasts - Now Available

PerkinElmer Launches Columbus™ 2.0 High Content Screening Platform for High-Volume Image Data Management and Analysis

Reportlinker Adds The Ophthalmic Pharmaceutical Market Outlook To 2014: Competitive Landscape, Pipeline Analysis, Growth Opportunities and Market Forecasts

EBD Group and Defined Health Form an Alliance on Conference Content

Blind Patient Regains Sight with “Eyetooth” Implanted in Her Eye

Los Angeles Cosmetic Surgeon Discusses Non-Surgical Facial Rejuvenation in Harper’s Bazaar Magazine

Pilkington Acquires License from Research Frontiers to Produce and Offer Environmentally Friendly SPD-Smart Automotive Glass Products

OptiMedica Names Alan Marquardt as New Vice President, Regulatory, Clinical and Quality

AzaSite® Production Increased in Response to Erythromycin Ophthalmic Ointment Shortage

Alcon to Acquire Swiss Biotechnology Firm, ESBATech AG

Fitch Ratings Affirms McKesson's IDR at 'BBB+'; Outlook Stable

Reportlinker Adds China Medical Equipment Market Analysis and Forecasts to 2015

Acucela Appoints Glen Y. Sato to Board of Directors

pSivida to Webcast Presentation at Rodman & Renshaw Health Care Conference

Amerinet Named Provider of Choice by National Rural Health Association Partnership

Lux Biosciences to Present at the Thomas Weisel Partners Health Care Conference

Hi-Tech Pharmacal to Release First Quarter Earnings and Hold Conference Call on September 9, 2009

Christopher Payan to Depart Emerging Vision

Vivakor Announces Award of Grant from the National Institutes of Health-National Eye Institute

Merck Launches SAFLUTAN® (tafluprost) in International Markets

Dioptics Launches Haven Fits Over Sunwear™

Acucela to Present at the Rodman & Renshaw 11th Annual Healthcare Conference

MedAssets to Present at Two Investor Conferences in September

Visiogen Announces Formation of European Subsidiary, Commencement of Controlled Commercial Release of Synchrony® Accommodating IOL

Research and Markets: A Global Strategic Analysis on the Intraocular Lenses Markets in Millions of US$

Alcon Fourth Quarter Diluted EPS Increased 12.8 Percent

Raquel Welch Stars in Foster Grant TV Commercial

Biotechs Seek Partners at BIO-Europe Spring® as Alternative to Financial Markets

Advanced Medical Optics, Inc. Gives Notice of Anticipated Fundamental Change and Merger to Holders of Convertible Senior Subordinated Notes

Allergan Reports Fourth Quarter 2008 Operating Results and Announces Restructuring

ACADIA Pharmaceuticals to Present at the BIO CEO & Investor Conference on February 10, 2009

Cataract Surgery and Macular Degeneration; Beauty in the Eye of the Beholder; Are Genes or Environmental Factors to Blame for Poorer Vision as We Age?

pSivida Corp. Names Paul Ashton, Ph.D. President and Chief Executive Officer

ZOLL Announces Filing of Patent Infringement Suit Against Alsius Corporation and Alsius Medical Corporation

Akorn Announces Management Change

International Stem Cell Corporation Begins Pre-Clinical Trials on Human Corneal Epithelial Cells

OPKO Receives FDA 510(k) Clearance for Spectral OCT SLO Combination Imaging System

Orange 21 Inc. Announces $7.6 Million Rights Offering

OPKO Health Initiates Clinical Trial of the Aquashunt™ to Treat Glaucoma

Larry C. Renfro Named Executive Vice President UnitedHealth Group and Ovations Chief Executive Officer

Simon Stevens Appointed Executive Vice President UnitedHealth Group to Lead Enterprise-Wide Health Care Reform Engagement; Will Also Direct International Businesses and Global Expansion

Genentech Announces Vice President Appointment in Research

Examine the Global Ophthalmic Market: Focus on Glaucoma

Online Resource Illustrates Basic Diagnosis Procedures for Medical School Students

MacuCLEAR and Mystic Pharmaceuticals Agree To Collaborate on Macular Degeneration Phase I/II Clinical Trial

CYTTA Introduces Its New Wholly Owned Subsidiary

Kevin Buehler Appointed President and CEO of Alcon; Cary Rayment to Continue as Chairman of the Board

Alcon Announces Fourth Quarter 2008 Financial Release and Conference Call Dates

High Growth Reported for the World Optical Coatings Market

Research and Markets: 'Global Ophthalmic Market: Focus On Glaucoma' Focuses on Glaucoma as a Major Ophthalmic Market

Medtech Insight and Windhover Conferences Announce their Upcoming "Investment In Innovation (In3) West” Conference March 2-4, 2009, Las Vegas, NV

Akorn-Strides, LLC Announces FDA Approvals for Sterile Vancomycin HCl USP, 500 mg/Vial; 1 g/Vial and Sterile Vancomycin HCl USP, 5 g/Vial Pharmacy Bulk Package

Eye Care and Eyewear Trends for 2009 and Beyond from the Editors of AllAboutVision.com

FDA Approves Alcon’s AcrySof® IQ ReSTOR® +3.0 D Intraocular Lens

Californian Files Consumer Fraud Class Action against Advanced Medical Optics for Falsely Advertising Contact Lens Solution

Californian Files Contact Lens Solution False Advertising Class Action Against Advanced Medical Optics, Announces the Schmidt Firm, LLP

Examine the World Intraocular Lenses Market